Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae

被引:33
作者
Gacar, GG
Midilli, K
Kolayli, F
Ergen, K
Gundes, S
Hosoglu, S
Karadenizli, A
Vahaboglu, H
机构
[1] Kocaeli Univ, Mikrobiyol & Klin Mikrobiyol AD, Kocaeli, Turkey
[2] Kocaeli Univ, Biofiz AD, Kocaeli, Turkey
[3] Kocaeli Univ, Enfeksiyon Hastaliklari & Klin Mikrobiyol AD, Kocaeli, Turkey
[4] Dicle Univ, Enfeksiyon Hastaliklari & Klin Mikrobiyol AD, Diyarbakir, Turkey
[5] Istanbul Univ, Mikrobiyol & Klin MIkrobiyol AD, Cerrahpasa Tip Fak, Istanbul, Turkey
关键词
D O I
10.1128/AAC.49.10.4400-4403.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A VIM-5-producing Enterobacter cloacae isolate (EDV/1) was identified in a collection of clinical strains stored before 2002. The gene, blav(VIM-5), was located on a 2,712-bp BamHI-HindIII fragment of a 23-kbp (approximately) nonconjugative plasmid (pEDV5) in a class 1 integron as a single gene cassette.
引用
收藏
页码:4400 / 4403
页数:4
相关论文
共 19 条
[1]   Detection of VIM-5 metallo-β-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey [J].
Bahar, G ;
Mazzariol, A ;
Koncan, R ;
Mert, A ;
Fontana, R ;
Rossolini, GM ;
Cornaglia, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :282-283
[2]   Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase [J].
Cornaglia, G ;
Mazzariol, A ;
Lauretti, L ;
Rossolini, GM ;
Fontana, R .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) :1119-1125
[3]   Purification and biochemical characterization of the VIM-1 metallo-β-lactamase [J].
Franceschini, N ;
Caravelli, B ;
Docquier, JD ;
Galleni, M ;
Frère, JM ;
Amicosante, G ;
Rossolini, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3003-3007
[4]   Characterization of a new integron containing blaVIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece [J].
Galani, I ;
Souli, M ;
Chryssouli, Z ;
Orlandou, K ;
Giamarellou, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) :634-638
[5]   Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates [J].
Giakkoupi, P ;
Tzouvelekis, LS ;
Daikos, GL ;
Miriagou, V ;
Petrikkos, G ;
Legakis, NJ ;
Vatopoulos, AC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :494-496
[6]   Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate [J].
Lauretti, L ;
Riccio, ML ;
Mazzariol, A ;
Cornaglia, G ;
Amicosante, G ;
Fontana, R ;
Rossolini, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1584-1590
[7]   Isolation of an integron-borne blaVIM-4 type metallo-β-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary [J].
Libisch, B ;
Gacs, M ;
Csiszár, K ;
Muzslay, M ;
Rókusz, L ;
Füzi, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3576-3578
[8]   Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase [J].
Lombardi, G ;
Luzzaro, F ;
Docquier, JD ;
Riccio, ML ;
Perilli, M ;
Colì, A ;
Amicosante, G ;
Rossolini, GM ;
Toniolo, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4051-4055
[9]   Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid [J].
Luzzaro, F ;
Docquier, JD ;
Colinon, C ;
Endimiani, A ;
Lombardi, G ;
Amicosante, G ;
Rossolini, GM ;
Toniolo, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :648-650
[10]  
Midilli K, 2003, P KLIMIK C TAV MATHB, P275